[ Back to EurekAlert! ]

PUBLIC RELEASE DATE:
15-Oct-2012

[ | E-mail ] Share Share

Contact: Jillian Hurst
press_releases@the-jci.org
Journal of Clinical Investigation
@jclinicalinvest

Scratching the surface of psoriasis

Psoriasis is a chronic inflammatory skin disorder that affects approximately 2% of the world's population. A group of inflammatory molecules known as interleukins activate an immune response that causes itchy skin, but it is unclear how the skin cells and immune cells communicate. In a study published in the Journal of Clinical Investigation, researchers led by Manfred Kopf at the Swiss Federal Institute of Technology in Zürich, Switzerland found that mice lacking interleukin-36 (IL-36) were protected from immune-mediated skin inflammation. These results indicate that IL-36 might be a useful therapeutic target in the treatment of psoriasis.

###

TITLE:

Psoriasiform dermatitis is driven by interleukin-36-mediated dendritic cell-keratinocyte crosstalk

AUTHOR CONTACT:

Manfred Kopf

Swiss Federal Institute of Technology, Zurich, , CHE

Phone: +41 44 633 6470; E-mail: Manfred.Kopf@ethz.ch

View this article at: http://www.jci.org/articles/view/63451?key=94c50375c771888cd255



[ Back to EurekAlert! ] [ | E-mail Share Share ]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.